Federal award
KBR WYLE SERVICES, LLC
0016
Contract
Obligated and Ceiling
- Obligated (net)
- $20,056,396.60
- Ceiling (potential value, not spending)
- $39,418,177.00
- Current value
- $39,418,177.00
- Gross positive obligations
- $31,636,150.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · L693MQDFLKD1
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR WYLE SERVICES, LLC · TGPKTMN8YL31
- Awarding agency
- Department of War · sub-agency 5700 · office FA8075
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- 0016
- Parent vehicle (IDV PIID)
- FA807514D0025
- Award type code
- C
- Actions
- 50 · Jun 20, 2016 to Jun 30, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History50
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 30, 2025 | FY2025 | 47 | M | $0.00 | |
| Jun 16, 2025 | FY2025 | 46 | C | −$1,495,369.03 | |
| Oct 17, 2022 | FY2023 | 1B | M | $0.00 | |
| Apr 28, 2022 | FY2022 | 1A | M | −$803,342.37 | |
| Feb 12, 2022 | FY2022 | 45 | M | $0.00 | |
| Aug 9, 2021 | FY2021 | 44 | C | −$1,327,609.00 | |
| May 3, 2021 | FY2021 | 43 | C | $34,733.00 | |
| Mar 4, 2021 | FY2021 | 42 | C | $160,118.00 | |
| Feb 5, 2021 | FY2021 | 41 | C | $989,609.00 | |
| Jan 14, 2021 | FY2021 | 40 | M | $0.00 | |
| Jan 12, 2021 | FY2021 | 39 | C | $831,180.00 | |
| Sep 10, 2020 | FY2020 | 38 | C | $829,881.00 | |
| Aug 20, 2020 | FY2020 | 37 | C | $2,483,397.00 | |
| Aug 4, 2020 | FY2020 | 36 | C | $1,959,265.00 | |
| Jul 21, 2020 | FY2020 | 35 | C | $894,584.00 | |
| May 21, 2020 | FY2020 | 34 | C | $185,000.00 | |
| Apr 13, 2020 | FY2020 | 33 | C | $120,000.00 | |
| Mar 30, 2020 | FY2020 | 32 | C | $201,796.00 | |
| Sep 18, 2019 | FY2019 | 31 | C | $154,455.00 | |
| Aug 26, 2019 | FY2019 | 30 | C | $475,101.00 | |
| Aug 5, 2019 | FY2019 | 29 | C | $1,405,326.00 | |
| Jul 10, 2019 | FY2019 | 28 | C | $1,934,200.00 | |
| Oct 31, 2018 | FY2019 | 27 | C | $267,983.00 | |
| Oct 16, 2018 | FY2019 | 26 | C | $375,443.00 | |
| Aug 3, 2018 | FY2018 | 25 | C | $966,534.00 | |
| Jul 16, 2018 | FY2018 | 24 | C | $1,212,669.00 | |
| Jul 5, 2018 | FY2018 | 23 | C | −$1,302,777.00 | |
| Jun 26, 2018 | FY2018 | 22 | C | $1,302,777.00 | |
| Apr 19, 2018 | FY2018 | 21 | C | $555,968.00 | |
| Jan 8, 2018 | FY2018 | 20 | C | $18,715.00 | |
| Dec 14, 2017 | FY2018 | 19 | C | $475,279.00 | |
| Aug 3, 2017 | FY2017 | 18 | C | $262,880.00 | |
| Jul 6, 2017 | FY2017 | 17 | C | $1,171,076.00 | |
| May 22, 2017 | FY2017 | 16 | C | $117,921.00 | |
| Apr 20, 2017 | FY2017 | 15 | C | $1,518,415.00 | |
| Apr 5, 2017 | FY2017 | 14 | C | −$6,650,656.00 | |
| Mar 22, 2017 | FY2017 | 13 | C | $1,651.00 | |
| Mar 8, 2017 | FY2017 | 12 | M | $0.00 | |
| Mar 7, 2017 | FY2017 | 11 | C | $102,798.00 | |
| Feb 27, 2017 | FY2017 | 10 | C | $6,650,656.00 | |
| Feb 6, 2017 | FY2017 | 9 | C | $668,000.00 | |
| Dec 8, 2016 | FY2017 | 8 | C | $760,000.00 | |
| Oct 17, 2016 | FY2017 | 7 | C | $140,000.00 | |
| Sep 6, 2016 | FY2016 | 6 | C | $86,000.00 | |
| Jul 13, 2016 | FY2016 | 5 | C | $406,000.00 | |
| Jul 6, 2016 | FY2016 | 4 | B | $0.00 | |
| Jul 1, 2016 | FY2016 | 3 | C | $393,500.00 | |
| Jun 30, 2016 | FY2016 | 2 | C | $65,370.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 29, 2016 | FY2016 | 1 | C | $262,500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 20, 2016 | FY2016 | 0 | — | $1,195,370.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
